Financials

Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-58.23
Rapporto prezzo/fatturato
97.79

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
988
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
83.71 USD+0.05%+0.19%+137.41%+103.67%8.83 B USD
999
SYRE
Spyre Therapeutics, Inc. - Common Stock
98.95 USD+5.57%+4.89%+18.45%+313.84%8.59 B USD
1010
TGTX
TG Therapeutics, Inc. - Common Stock
54.89 USD-0.22%-4.72%+9.47%+43.35%8.40 B USD
1017
APGE
Apogee Therapeutics, Inc. - Common Stock
133.96 USD+0.10%+0.33%+55.42%+149.97%8.29 B USD

Notizie